Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode

Summary

The aim of this clinical investigation is to find out whether the EMOCARE emotional monitoring software provides consistent results compared with the tools available for assessing the emotional state of patients suffering from mild to moderately severe depressive episod. It will also provide information on how patients feel about the use of passive monitoring software (without the active involvement of patient). The main questions it aims to answer are as follows:

Does EMOCARE provide consistent results compared with tools already used in current practice? What are the medical problems encountered by participants when using EMOCARE?

The researchers will compare EMCOCARE to various questionnaires usually used in the management of patients suffering from depression (PHQ-9, MADRS, GAD-7, BDI-II, EQ-5D-5L).

Participants who agree to take part in the study, during a selection visit, will be able to:

1. Install the software on a digital interface (smartphone, computer, etc.) and activate or deactivate it whenever they wish during the 6-week follow-up period.
2. Attend 2 scheduled appointments at the centre (a first appointment then a second 6 weeks later) to complete a series of questionnaires, being questioned by the doctor, and fill in other questionnaires on their own.
3. At home, answer questionnaires independently, 2 weeks and 4 weeks after the first appointment.
4. Receive a telephone call from the doctor 3 weeks after the first appointment to find out how the participants are feeling.
5. Keep a diary with the symptoms they have experienced, any medical consultations they have made, or changes in drug treatment.

Conditions

• Major Depressive Disorder (MDD)

Interventions

DEVICE

EMOCARE software

Use of the EMOCARE software on the digital device of participant (smartphone, computer, etc.). The participant can activate and deactivate the software whenever he wishes.

Sponsors & Collaborators

• Nantes University Hospital

  collaborator OTHER

• Private psychiatric practice, Saint-Nazaire

  collaborator UNKNOWN

• Groupement Hospitalier Paul Guiraud, Villejuif

  collaborator UNKNOWN

• Centre Hospitalier Guillaume Régnier, RENNES

  collaborator UNKNOWN

• Centre de Psychothérapie Nancéen, Laxou

  collaborator UNKNOWN

• Rumb

  collaborator UNKNOWN

• Private psychiatric pratice, Agen

  collaborator UNKNOWN

• Private psychiatric pratice, Caen

  collaborator UNKNOWN

• Emobot

  lead INDUSTRY

Study Design

Allocation

NA

Purpose

OTHER

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-03-05

Primary Completion

2027-02-04

Completion

2027-02-04

Countries

• France

Study Locations